Science and industry partner

YUMAB is a biotech company founded in 2012 by scientists of the Technical University of Braunschweig. Specializing in the generation and optimization of recombinant antibodies for therapy and diagnostics, YUMAB has rapidly grown to one of the world leaders in the development of fully human antibodies. The experts behind YUMAB have more than 30 years of experience in the field of recombinant antibodies by always using the latest technologies. In order to push forward innovation, YUMAB also collaborates with partners worldwide. This combination makes it possible to offer novel solutions to current and future challenges in the area of therapeutic antibodies.

© Photos: Verena Meier